XML 80 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill and Other Intangible Assets
12 Months Ended
Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets
Under ASC 350, Intangibles—Goodwill and Other, goodwill is not subject to amortization. We evaluate goodwill for impairment at least annually or more frequently if events and changes in circumstances suggest that the carrying amount may not be recoverable. During 2012, we adopted the qualitative approach for assessing goodwill impairment. For additional details on our policy regarding the valuation and impairment of goodwill, other intangible assets and other long lived assets, see Note 1, "Organization and Summary of Significant Accounting Policies" to the Notes to Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K.
Activity in goodwill by reporting units, which are the same as our operating segments, for the year ended December 31, 2012 consists of the following (in thousands):
 
Goodwill at December 31, 2011
 
Goodwill acquired
 
Goodwill at December 31, 2012
Reporting units:
 
 
 
 
 
Acute Care
$
28,543

 
$

 
$
28,543

Non-Acute Care

 
82,864

 
82,864

Total
$
28,543

 
$
82,864

 
$
111,407


The goodwill acquired reflects the May 2012 acquisition of MedPak by Omnicell. MedPak is the parent company of MTS, a worldwide provider of medication adherence packaging systems. The acquired goodwill was assigned to the Non-Acute Care segment, created as a result of the MTS acquisition.
There were no indefinite-life intangibles at either December 31, 2012 or December 31, 2011. Finite-life intangible assets at these dates consist of the following (in thousands):
 
December 31, 2012
 
December 31, 2011
 
 
 
Gross
 
 
 
Net
 
Gross
 
 
 
Net
 
 
 
Carrying
Amount
 
Accumulated
Amortization
 
Carrying
Amount
 
Carrying
Amount
 
Accumulated
Amortization
 
Carrying
Amount
 
Amortization
Life
Finite-lived intangibles:
 

 
 

 
 

 
 

 
 

 
 

 
 
Customer relationships
$
54,730

 
$
3,081

 
$
51,649

 
$
4,230

 
$
1,591

 
$
2,639

 
5-30 years
Acquired technology
27,580

 
1,128

 
26,452

 
980

 
175

 
805

 
3-20 years
Patents
1,217

 
259

 
958

 
889

 
190

 
699

 
20 years
Trade name
6,890

 
414

 
6,476

 
90

 
37

 
53

 
3-12 years
Non-compete agreements
60

 
45

 
15

 
60

 
25

 
35

 
3 years
Total finite-lived intangibles
$
90,477

 
$
4,927

 
$
85,550

 
$
6,249

 
$
2,018

 
$
4,231

 
 
 
During 2012, 2011 and 2010, we capitalized third-party costs associated with internally-developed patent costs of $0.4 million, $0.2 million and $0.2 million, respectively.
Amortization expense of other intangible assets totaled $2.9 million, $0.7 million and $2.2 million for the years ended December 31, 2012, 2011 and 2010, respectively. The amortization of acquired technology is included within product cost of sales; other acquired intangibles are usually amortized within selling, general and administrative expenses.
Estimated annual expected amortization expense of the finite-lived intangible assets at December 31, 2012 was as follows (in thousands):
2013
$
4,265

2014
4,224

2015
4,200

2016
3,850

2017
3,814

Thereafter
65,197

Total
$
85,550